Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pharmala Biotech Holdings Inc
C.MDMA
Alternate Symbol(s):
MDXXF
PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines...
: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:MDMA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(157)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Mar 09, 2023 12:33pm
come with me
and short PMET!!!
(2)
•••
montysmoney
X
View Profile
View Bullboard History
Post by
montysmoney
on Mar 09, 2023 12:29pm
$$XBRA First Company cannabis license in Mexico
Xebra receives Mexico's first cannabis authorizations 2023-03-09 11:29 ET - News Release Mr. Jay Garnett reports MEXICAN GOVERNMENT GRANTS XEBRA BRANDS THE FIRST
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(23)
•••
thedave2006
X
View Profile
View Bullboard History
Post by
thedave2006
on Mar 09, 2023 11:49am
great action
into 0.20s
(83)
•••
goldboyz2
X
View Profile
View Bullboard History
Comment by
goldboyz2
on Mar 09, 2023 10:55am
RE:Interesting earnings potential
Interesting indeed! 720k shares wall at 20 cents. hopefully blow through it GB
(14)
•••
hcdtrading
X
View Profile
View Bullboard History
Post by
hcdtrading
on Mar 08, 2023 4:46pm
Broke the wall at .16 here we go
Dave is correct to point out this is still only 14 million mcap. After todays close it is setting up very bullish for the rest of the week. Will see how it plays out... My target is .25 which could
...more
(23)
•••
thedave2006
X
View Profile
View Bullboard History
Post by
thedave2006
on Mar 08, 2023 3:21pm
Interesting earnings potential
Still only $14M mc.
(14)
•••
hcdtrading
X
View Profile
View Bullboard History
Post by
hcdtrading
on Mar 06, 2023 11:17pm
Hitting a wall at .16
I think this stock can get into the .20s but will have to get through that .16 wall
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 06, 2023 7:00am
New Press Release - Mindset Pharma and PharmAla Complete First Sale of Pharmaceutical Grade Psilocybin Into Growing Australian Market via Sales Partnership
TORONTO, March 06, 2023 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery company developing novel, optimized, next-generation psychedelic and non-psychedelic medications to treat neuropsychiatric and neurological...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 02, 2023 8:35am
New Press Release - PharmAla Biotech named Exclusive MDMA Supply Partner to Awakn Life Sciences
PharmAla will be the sole provider of both GMP and Engineering MDMA to Awakn VANCOUVER, British Columbia, March 02, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA), a biotechnology company focused on the research, development, and manufacturing of MDXX class...
read article.
(23)
•••
thedave2006
X
View Profile
View Bullboard History
Post by
thedave2006
on Mar 01, 2023 11:16am
anything here
besides fomo?
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 01, 2023 8:00am
New Press Release - PharmAla Biotech Completes Annual General Meeting
All Motions Adopted Amidst Significant Market Interest in PharmAla as a Leading GMP Manufacturer and Researcher of MDMA and Analog molecules TORONTO, March 01, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech (CSE:MDMA) has completed its first Annual General Meeting as a publicly-traded company. The...
read article.
(4)
•••
marcassin
X
View Profile
View Bullboard History
Post by
marcassin
on Feb 27, 2023 1:21pm
takeover for sure.
This company will be bought by a big pharma. Too much money to do and nothing to built because they already having in hand.
(157)
•••
Chefboy69
X
View Profile
View Bullboard History
Post by
Chefboy69
on Feb 27, 2023 10:00am
I am terrible at picking stocks
LMAO congrats all
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 23, 2023 8:00am
New Press Release - Patent Application Published for PharmAla Biotech's MDMA Analogs
Patent covers 6 novel compositions of matter, which PharmAla has been studying in preclinical testing for over a year VANCOUVER, British Columbia, Feb. 23, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech (CSE:MDMA) is pleased to announce the publication of a key Patent Cooperation Treaty (PCT...
read article.
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >